-
公开(公告)号:EP4317174A1
公开(公告)日:2024-02-07
申请号:EP22775599.8
申请日:2022-03-22
申请人: Peptiaid Inc , Japan as Represented by The Director-General of National Institute of Infectious Diseases
发明人: WATASHI, Koichi , OHASHI, Hirofumi , MASUYA, Keiichi , OHUCHI, Masaki , KURASAKI, Haruaki , MATSUI, Katsuma , NAGASAWA, Takayuki , YAMAMOTO, Junpei , NAGATOMO, Kazutaka , SUDO, Kei , NAKAMURA, Naoko , YOSHIDA, Koji , SHIMADA, Yoshiaki , NIIMI, Tatsuya , MASUDA, Yoshiaki , IWATA, Naoko , SHIWA, Nozomi , NAGATA, Noriyo , SUZUKI, Tadaki , KITAMURA, Hidetomo
IPC分类号: C07K7/08 , A61K38/10 , A61K38/12 , A61K39/395 , A61P31/14 , G01N33/569
摘要: The present invention relates to a peptide and a composition comprising the peptide. This peptide of the present invention comprises the following amino acid sequence: MeA-MeF-S-Cha-Y-S-Y-Y-R-R-Cha-C (SEQ ID NO: 2) or an amino acid sequence having a substitution, addition, deletion, or insertion in 1 to 10 amino acid residues selected from the group consisting of amino acid residues at positions 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 in the above amino acid sequence.